Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2019
FDA reform: it’s time to act, but not as an independent agency
19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...
Posted by Michael Wonder on 13 Mar 2019
Women with advanced breast cancer ask health select committee for PHARMAC review
13 March 2019 - Ten women today spoke one after the other, telling a committee of MPs how desperately they ...
Posted by Michael Wonder on 06 Mar 2019
Outcomes and impacts of 10 year HTA implementation in Taiwan
28 February 2019 - In 2007, Taiwan began conducting health technology assessments to support the National Health Insurance Administration in ...
Posted by Michael Wonder on 28 Feb 2019
After 16 reviews we know how to fix health care, experts say
28 February 2019 - After 16 national reviews in 35 years, the road map for improving the health care system ...
Posted by Michael Wonder on 26 Feb 2019
Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday
26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...
Posted by Michael Wonder on 26 Feb 2019
Procedural update on submission of Type I variations to EMA in March, April and May 2019
26 February 2019 - EMA is encouraging marketing authorisation holders intending to submit Brexit-related Type IA and Type IB variations ...
Posted by Michael Wonder on 13 Feb 2019
PHARMAC to review its practices following criticism of breast cancer drug funding
13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...
Posted by Michael Wonder on 10 Feb 2019
How procurement judges the value of medical technologies: a review of health care tenders
8 February 2019 - Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health ...
Posted by Michael Wonder on 17 Jan 2019
ICER to assess whether the most significant prescription drug price increases are supported by new clinical evidence
17 January 2019 - Public comments on draft protocol will be accepted through 13 February 2019. ...
Posted by Michael Wonder on 10 Jan 2019
2018 in a nutshell: new edition with facts and graphics from the IQWiG
9 January 2019 - The focus of the 33-page brochure is information, overviews and charts on "Health Technology Assessment (HTA) ...
Posted by Michael Wonder on 07 Jan 2019
PBAC - 2018 in review
7 January 2019 - The PBAC considered 195 submissions in 2018; 173 were considered by the PBAC in 2017. ...
Posted by Michael Wonder on 28 Oct 2018
Calls for PHARMAC review after funds made available to offset wage settlements
24 October 2018 - A request that the government's drug-buying agency be reviewed has opposition support with claims money is ...
Posted by Michael Wonder on 11 Oct 2018
Ethics in health technology assessment: a systematic review
9 October 2018 - Integration of ethics into health technology assessment remains challenging for HTA practitioners. ...
Posted by Michael Wonder on 08 Oct 2018
Revised process for ultra-orphan medicines
8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...
Posted by Michael Wonder on 27 Sep 2018
TGA annual performance statistics report: July 2017 to June 2018
27 September 2018 - The statistics contained within this report cover the period 1 July 2017 to 30 June 2018, ...